Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ulipristal Acetate Therapy Versus Uterine Artery Embolization in Management of Uterine Fibroids

NCT04832906 is registered in ClinicalTrials.gov with Ain Shams Maternity Hospital as lead sponsor.

NCT NCT04832906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04832906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ulipristal Acetate Therapy Versus Uterine Artery Embolization in Management of Uterine Fibroids
Lead sponsor
Ain Shams Maternity Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 13, 2019
Completion date
March 13, 2021
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uterine fibroid